Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Article numbere009579
JournalBMJ Open
Volume5
Issue number11
DOIs
Publication statusPublished - 2015

Cite this